Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit a new 52-week low at Rs 4.94, marking the maximum daily loss permitted by the 5% price band. The closing last traded price (LTP) was Rs 5.18, with the intraday range spanning from a high of Rs 5.25 to the circuit low of Rs 4.94. This price action reflects a scenario where supply overwhelmed demand to the point where the circuit breaker intervened, effectively freezing trading at the floor price. Sellers were lined up at the lower circuit price, but buyers were absent, creating a classic case of unfilled supply — a situation that often exacerbates exit difficulties for holders in micro-cap stocks like Vivimed Labs Ltd.

Delivery and Volume Analysis

Delivery volumes on 28 Jul 2026 rose by 3.6% compared to the 5-day average, with 9,900 shares delivered. On a lower circuit day, rising delivery volume is a significant indicator — it means that holders are liquidating actual positions rather than speculative short-selling. This genuine selling pressure suggests capitulation or forced liquidation rather than intraday trading activity. The total traded volume on 29 Jul was 65,530 shares, with a turnover of just ₹0.033 crore, reflecting the mechanical volume suppression caused by the circuit lock rather than a reduction in selling intent. Vivimed Labs Ltd’s delivery data on this day highlights the severity of the sell-off and raises the question whether the selling in Vivimed Labs has reached capitulation or whether more exits remain ahead.

Intraday Price Action

The intraday price arc was notable for its breadth. The stock opened near Rs 5.25, trading above the previous close before succumbing to selling pressure that pushed it down to the circuit floor at Rs 4.94. This represents a 5.9% intraday decline, slightly exceeding the 5% price band due to the opening premium. The rapid descent from the high to the lower circuit price underscores the intensity of the sell-off and the absence of meaningful buying interest throughout the session. Does this intraday collapse signal exhaustion or is it a prelude to further weakness?

Moving Averages and Trend Context

Technically, Vivimed Labs Ltd closed above its 5-day moving average but remained below the 20-day, 50-day, 100-day, and 200-day moving averages. This positioning indicates that while very short-term momentum may have some support, the broader trend remains firmly negative. The stock’s failure to reclaim these longer-term averages confirms the prevailing weakness and suggests that the lower circuit event is an acceleration of an already bearish trend rather than an isolated shock. Does the technical profile of Vivimed Labs show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of approximately ₹43 crore, Vivimed Labs Ltd is classified as a micro-cap stock. Its liquidity profile is modest, with a total turnover of ₹0.033 crore on the circuit day and a trade size capacity effectively near zero based on 2% of the 5-day average traded value. This limited liquidity compounds the exit risk for sellers, as the lower circuit locks in losses but also traps holders who cannot find buyers at these levels. The unfilled supply at Rs 4.94 and the thin trading volumes create a scenario where meaningful exits are difficult, raising the possibility of multi-day circuit locks if selling pressure persists. With unfilled sell orders at Rs 4.94 and near-zero liquidity, how deep is the exit problem for Vivimed Labs and what would need to change for normal trading to resume?

Fundamental Context

Vivimed Labs Ltd operates in the Pharmaceuticals & Drugs industry, a sector often subject to regulatory and market volatility. While fundamentals are not the focus here, the micro-cap status and recent price action suggest that market sentiment and liquidity constraints are currently the dominant forces shaping the stock’s performance.

Conclusion: Severity and Liquidity Caveats

The 5% lower circuit lock at Rs 4.94 for Vivimed Labs Ltd reflects a session dominated by genuine selling pressure, as evidenced by rising delivery volumes and a wide intraday price range. The stock’s position below key moving averages confirms the prevailing downtrend, while its micro-cap status and limited liquidity exacerbate exit risks for holders. The circuit breaker has halted the price decline but also trapped sellers who arrived too late to exit, raising the question after a 5% single-day loss at lower circuit, is Vivimed Labs approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today